Clinical Trial Reimbursement: Are You Penalising Patients?

When a participant joins a study, they provide a vital service to medical science. Yet, far too often, those same individuals are penalised when they try to access their own reimbursement and stipend payments.

If your trials still rely on prepaid cards, you are creating unnecessary friction that hinders both patient satisfaction and site efficiency.

Why are prepaid cards a barrier to clinical trial reimbursement?

Prepaid card systems create several hidden costs that impact your participants. These financial barriers often include:

• • ATM and withdrawal fees: Participants frequently lose £2 to £4 in fees just to access their own funds.
    
    
  • Inactivity fees: Monthly charges erode the balance if the card remains unused.

• • Replacement costs: Subjects are often charged £10 or more to replace a lost or expired card.

How do the April 2026 clinical trial mandates impact patient payments?

The industry is counting down to the major regulatory shift arriving on 28 April 2026. These new UK clinical trial regulations place a significant emphasis on patient-centricity.

Sponsors must now demonstrate that they are reducing burdens on participants, not adding to them. Charging your participants to access their own reimbursement contradicts the spirit of these reforms. Transparency and fairness are now regulatory priorities, and outdated payment models create friction that complicates compliance.

How can vHelp improve participant payments and compliance?

vHelp is designed to align with the evolving regulatory landscape. By delivering direct-to-bank payments within 24 hours, vHelp ensures that the participant receives 100% of their money.

Eliminating these fees is not just good for the participant experience. It is a critical step in ensuring your trial processes are robust, ethical, and fully prepared for the April 2026 compliance standards.

Don't let your payment system become a liability. Switch to a modern, participant-first payment model today.